APG Asset Management
AMPH icon

APG Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

APG Asset Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-13,400
Closed -$384K – 788
2022
Q3 		$384K Sell
13,400
-3,800
-22% -$124K ﹤0.01% 768
2022
Q2 		$572K Sell
17,200
-12,800
-43% -$457K ﹤0.01% 722
2022
Q1 		$968K Buy
+30,000
New +$851K ﹤0.01% 684

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

APG Asset Management's AMPH Position: Q4 2022 in Review

APG Asset Management sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2022, closing a stake of 13,400 shares — an estimated $384K sold.

APG Asset Management first reported a position in AMPH in Q1 2022 and held it in 3 quarters. The position peaked at $968K in Q1 2022. 211 funds tracked by Wall St. Rank hold AMPH as of Q4 2022.

  • APG Asset Management reported no remaining Amphastar Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • APG Asset Management sold 13,400 Amphastar Pharmaceuticals shares in Q4 2022, an estimated $384K.
  • APG Asset Management first reported a position in Amphastar Pharmaceuticals in Q1 2022 and held it in 3 quarters.
  • APG Asset Management's Amphastar Pharmaceuticals position peaked at $968K in Q1 2022.
  • 211 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2022.

Based on APG Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.